Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


Chembio Diagnostics, Inc. 

3661 Horseblock Road

Medford  New York  11763  U.S.A.
Phone: 631-924-1135 Fax: 631-924-6033


View Clinical Trials from BioPharm Insight

 Company News
Chembio Diagnostics, Inc. (CEMI.OB) Acquires Rights To SURE CHECK® HIV 1/2 Assay Effective June 1, 2016 1/22/2015 7:46:46 AM
Chembio Diagnostics, Inc. (CEMI.OB) Update On DPP™ Ebola And DPP™ Febrile Illness Assays 1/12/2015 8:37:54 AM
Chembio Diagnostics, Inc. (CEMI.OB) Appoints Paul Lambotte As Vice President, Product Development 1/8/2015 10:12:44 AM
Chembio Diagnostics, Inc. (CEMI.OB) To Present At The Biotech Showcase 2015 Conference 1/7/2015 7:44:50 AM
Chembio Diagnostics, Inc. (CEMI.OB) DPP® Technology To Be Used In Development Of Point-Of-Care Diagnostic Test For Traumatic Brain Injury And Sports-Related Concussion 1/6/2015 12:53:13 PM
Chembio Diagnostics, Inc. (CEMI.OB) Signs Agreement With CDC Contractor To Develop A Multiplex Point-Of-Care Test For Influenza Immunity 11/24/2014 1:34:32 PM
Chembio Diagnostics, Inc. (CEMI.OB) Reports Third Quarter 2014 Financial Results 11/6/2014 12:54:32 PM
Chembio Diagnostics, Inc. (CEMI.OB)'s DPP® HIV 1/2 Assay Receives CLIA Waiver From FDA 10/30/2014 7:41:09 AM
Chembio Diagnostics, Inc. (CEMI.OB) Announces Agreements To Develop Point-Of-Care Diagnostic Tests For Dengue Fever Virus And A Specific Type Of Cancer 10/28/2014 7:41:56 AM
Chembio Diagnostics, Inc. (CEMI.OB) Partners With Integrated BioTherapeutics To Develop Point-Of-Care Diagnostic Tests For Ebola And Febrile Illness 10/27/2014 10:18:31 AM